This board has been migrated to our new platform! Check out the new home page at discussion.fool.com or click below to go directly to the new Board on the new site.
9 Meters Biopharma : https://9meters.com/Pipeline: https://9meters.com/pipeline/1) The only phase 3 celiac drug in existence 2) Phase 2 orphan status for short bowel syndrome3) Phase 2 results expected this quarter4) Has a potential combined US revenue of over 1 billion and having rights for both as well.5) Other drugs in the pipeline.(See pipeline)6) Has a lot of insider buys.7) Recent analyst coverage.8) Excellent management team in place with proven history.I have been acquiring this stock over the past 4 months. I am treating this investment as a ST and Long Term, meaning I drop at different points while maintaining a 1/4 of my investment in to next year for the Celiac results and Lorazotide. I've touched upon highlights I find interesting but as always, do your own DD :)
Best Of |
Favorites & Replies |
My Fool |